These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28843946)

  • 1. Corrigendum to "Ferroportin disease: A systematic meta-analysis of clinical and molecular findings" J. Hepatol. 2010 Nov;53(5):941-949.
    Mayr R; Janecke AR; Schranz M; Griffiths WJH; Vogel W; Pietrangelo A; Zoller H
    J Hepatol; 2011 Sep; 55(3):734-736. PubMed ID: 28843946
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to: Hepatitis C virus NS2 protein triggers endoplasmic reticulum stress and suppresses its own viral replication [J Hepatol. 2010 Nov;53(5):797–804].
    J Hepatol; 2011 Jul; 55(1):239. PubMed ID: 28463552
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to "The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis: Results of a 9 year cohort follow-up" J. Hepatol. 2010 Nov; 53(5):911-917.
    Jones DE; Al-Rifai A; Frith J; Patanwala I; Newton JL
    J Hepatol; 2011 Sep; 55(3):737. PubMed ID: 28843947
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to 'An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs' [J Hepatol 2021;75(3):572-581].
    Cordell HJ; Fryett JJ; Ueno K; Darlay R; Aiba Y; Hitomi Y; Kawashima M; Nishida N; Khor SS; Gervais O; Kawai Y; Nagasaki M; Tokunaga K; Tang R; Shi Y; Li Z; Juran BD; Atkinson EJ; Gerussi A; Carbone M; Asselta R; Cheung A; de Andrade M; Baras A; Horowitz J; Ferreira MAR; Sun D; Jones DE; Flack S; Spicer A; Mulcahy VL; Byun J; Han Y; Sandford RN; Lazaridis KN; Amos CI; Hirschfield GM; Seldin MF; Invernizzi P; Siminovitch KA; Ma X; Nakamura M; Mells GF; ; ; ; ; ; ;
    J Hepatol; 2022 Feb; 76(2):489. PubMed ID: 34895949
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to: "An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs" [J Hepatol 75 (2021) 572-581].
    Cordell HJ; Fryett JJ; Ueno K; Darlay R; Aiba Y; Hitomi Y; Kawashima M; Nishida N; Khor SS; Gervais O; Kawai Y; Nagasaki M; Tokunaga K; Tang R; Shi Y; Li Z; Juran BD; Atkinson EJ; Gerussi A; Carbone M; Asselta R; Cheung A; de Andrade M; Baras A; Horowitz J; Ferreira MAR; Sun D; Jones DE; Flack S; Spicer A; Mulcahy VL; Byan J; Han Y; Sandford RN; Lazaridis KN; Amos CI; Hirschfield GM; Seldin MF; Invernizzi P; Siminovitch KA; Ma X; Nakamura M; Mells GF; ; ; ; ; ;
    J Hepatol; 2023 Apr; 78(4):883. PubMed ID: 36639314
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis" [J Hepatol 71 (2019) 543-552].
    Yau T; Hsu C; Kim TY; Choo SP; Kang YK; Hou MM; Numata K; Yeo W; Chopra A; Ikeda M; Kuromatsu R; Moriguchi M; Chao Y; Zhao H; Anderson J; Dela Cruz C; Kudo M
    J Hepatol; 2019 Dec; 71(6):1278. PubMed ID: 31668671
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Alveolar echinococcosis: From a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years" [J Hepatol 49 (2008) 72-77].
    Torgerson PR; Schweiger A; Deplazes P; Pohar M; Reichen J; Ammann RW; Tarr PE; Halkic N; Müllhaupt B
    J Hepatol; 2018 Nov; 69(5):1208. PubMed ID: 30206019
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "EASL Clinical Practice Guidelines on haemochromatosis" [J Hepatol 2022 (77) 479-502].
    ;
    J Hepatol; 2023 Nov; 79(5):1341. PubMed ID: 37770291
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "EASL clinical practice guidelines on the management of hepatic encephalopathy" [J Hepatol 2022 (77) 807-824].
    ;
    J Hepatol; 2023 Nov; 79(5):1340. PubMed ID: 37758523
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "EASL clinical practice guidelines on sclerosing cholangitis" [J Hepatol (77) 761-806].
    ;
    J Hepatol; 2023 Nov; 79(5):1339. PubMed ID: 37735011
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "EASL clinical practice guidelines on the management of cystic liver diseases" [J Hepatol (77) 1083-1108].
    ;
    J Hepatol; 2023 Nov; 79(5):1338. PubMed ID: 37726183
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "EASL-ILCA clinical practice guidelines on the management of intrahepatic cholangiocarcinoma" [J Hepatol (79) (2023) 181-208].
    ;
    J Hepatol; 2023 Nov; 79(5):1342. PubMed ID: 37748953
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma" [J Hepatol 69 (2018) 182-236].
    European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu
    J Hepatol; 2019 Apr; 70(4):817. PubMed ID: 30739718
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies" [J hepatol 67 (2017) 999-1008].
    Bruix J; Cheng AL; Meinhardt G; Nakajima K; De Sanctis Y; Llovet J
    J Hepatol; 2018 Oct; 69(4):990-991. PubMed ID: 30104026
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to 'Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis' [J Hepatol 75 (2021) 865-878].
    Pinyol R; Torrecilla S; Wang H; Montironi C; Piqué-Gili M; Torres-Martin M; Wei-Qiang L; Willoughby CE; Ramadori P; Andreu-Oller C; Taik P; Lee YA; Moeini A; Peix J; Faure-Dupuy S; Riedl T; Schuehle S; Oliveira CP; Alves VA; Boffetta P; Lachenmayer A; Roessler S; Minguez B; Schirmacher P; Dufour JF; Thung SN; Reeves HL; Carrilho FJ; Chang C; Uzilov AV; Heikenwalder M; Sanyal A; Friedman SL; Sia D; Llovet JM
    J Hepatol; 2021 Dec; 75(6):1515. PubMed ID: 34627652
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Targeting the gut-liver axis in liver disease" [J Hepatol 67 (2017) 1084-1103].
    Wiest R; Albillos A; Trauner M; Bajaj JS; Jalan R
    J Hepatol; 2018 Jun; 68(6):1336. PubMed ID: 29655855
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis" [J Hepatol 69 (2018) 406-460].
    ;
    J Hepatol; 2018 Nov; 69(5):1207. PubMed ID: 30172388
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to: "Portopulmonary hypertension in the current era of pulmonary hypertension management" [J Hepatol (2020);73:130-139].
    Savale L; Guimas M; Ebstein N; Fertin M; Jevnikar M; Renard S; Horeau-Langlard D; Tromeur C; Chabanne C; Prevot G; Chaouat A; Moceri P; Artaud-Macari É; Degano B; Tresorier R; Boissin C; Bouvaist H; Simon AC; Riou M; Favrolt N; Palat S; Bourlier D; Magro P; Cottin V; Bergot E; Lamblin N; Jaïs X; Coilly A; Durand F; Francoz C; Conti F; Hervé P; Simonneau G; Montani D; Duclos-Vallée JC; Samuel D; Humbert M; De Groote P; Sitbon O
    J Hepatol; 2020 Nov; 73(5):1293-1294. PubMed ID: 32907706
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Impaired brain glymphatic flow in experimental hepatic encephalopathy" [J Hepatol 69 (2019) 40-49].
    Hadjihambi A; Harrison IF; Costas-Rodríguez M; Vanhaecke F; Arias N; Gallego-Durán R; Mastitskaya S; Hosford PS; Olde Damink SWM; Davies N; Habtesion A; Lythgoe MF; Gourine AV; Jalan R
    J Hepatol; 2019 Mar; 70(3):582. PubMed ID: 30616987
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Pharmacotherapy for NASH: Current and emerging" [J Hepatol 68 (2017) 362-375].
    Konerman MA; Jones JC; Harrison SA
    J Hepatol; 2018 Jun; 68(6):1337. PubMed ID: 29567301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.